Biotech and Bristol-Myers Squibb published positive global phase 2 data from Pumitamig in advanced non-small cell lung cancer progressing after immunotherapy combined with chemotherapy.

Zhitongcaijing · 4d ago
Biotech and Bristol-Myers Squibb published positive global phase 2 data from Pumitamig in advanced non-small cell lung cancer progressing after immunotherapy combined with chemotherapy.